APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Opioids

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Synthetic Opioids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174039200320 December 2025193 pages

Choose your research edition.

Industry ResearchSynthetic Opioids Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Opioids Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Synthetic Opioids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Opioids Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Opioids Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Synthetic Opioids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Synthetic Opioids include Endo International, Impax Laboratories, Indivior, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, West-Ward Pharmaceuticals, Pfizer and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Synthetic Opioids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Synthetic Opioids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Synthetic Opioids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Synthetic Opioids market size, projected growth trends, production technologies, key applications, and end-use industries.

Synthetic Opioids Segment by Company

Endo International

Impax Laboratories

Indivior

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

West-Ward Pharmaceuticals

Pfizer

Mylan

Teva Pharmaceuticals

Synthetic Opioids Segment by Type

Hydrocodone

Oxymorphone

Oxycodone

Meperidine

Methadone

Fentanyl

Synthetic Opioids Segment by Application

Pain Management

De-addiction

Synthetic Opioids Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Opioids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Opioids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Opioids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Synthetic Opioids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Synthetic Opioids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Synthetic Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Synthetic Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Synthetic Opioids Industry Trends Table 2. Synthetic Opioids Industry Drivers Table 3. Synthetic Opioids Industry Opportunities and Challenges Table 4. Synthetic Opioids Industry Restraints Table 5. Global Synthetic Opioids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Synthetic Opioids Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Synthetic Opioids Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Synthetic Opioids Sales Market Share by Manufacturers Table 9. Global Synthetic Opioids Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Synthetic Opioids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Synthetic Opioids Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Synthetic Opioids Manufacturers, Product Type & Application Table 13. Global Synthetic Opioids Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Synthetic Opioids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hydrocodone Table 17. Major Manufacturers of Oxymorphone Table 18. Major Manufacturers of Oxycodone Table 19. Major Manufacturers of Meperidine Table 20. Major Manufacturers of Methadone Table 21. Major Manufacturers of Fentanyl Table 22. Global Synthetic Opioids Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 24. Global Synthetic Opioids Sales by Type (2027-2032) & (K Units) Table 25. Global Synthetic Opioids Sales Market Share by Type (2021-2026) Table 26. Global Synthetic Opioids Sales Market Share by Type (2027-2032) Table 27. Global Synthetic Opioids Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Synthetic Opioids Revenue by Type (2021-2026) & (K Units) Table 29. Global Synthetic Opioids Revenue by Type (2027-2032) & (K Units) Table 30. Global Synthetic Opioids Revenue Market Share by Type (2021-2026) Table 31. Global Synthetic Opioids Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Pain Management Table 33. Major Manufacturers of De-addiction Table 34. Global Synthetic Opioids Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 36. Global Synthetic Opioids Sales by Application (2027-2032) & (K Units) Table 37. Global Synthetic Opioids Sales Market Share by Application (2021-2026) Table 38. Global Synthetic Opioids Sales Market Share by Application (2027-2032) Table 39. Global Synthetic Opioids Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Synthetic Opioids Revenue by Application (2021-2026) & (K Units) Table 41. Global Synthetic Opioids Revenue by Application (2027-2032) & (K Units) Table 42. Global Synthetic Opioids Revenue Market Share by Application (2021-2026) Table 43. Global Synthetic Opioids Revenue Market Share by Application (2027-2032) Table 44. Global Synthetic Opioids Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Synthetic Opioids Sales by Region (2021-2026) & (K Units) Table 46. Global Synthetic Opioids Sales Market Share by Region (2021-2026) Table 47. Global Synthetic Opioids Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Synthetic Opioids Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 51. North America Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 52. Europe Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 54. Europe Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 61. Global Synthetic Opioids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Synthetic Opioids Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Synthetic Opioids Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Synthetic Opioids Revenue Market Share by Region (2021-2026) Table 65. Global Synthetic Opioids Revenue Market Share by Region (2027-2032) Table 66. Endo International Company Information Table 67. Endo International Business Overview Table 68. Endo International Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Endo International Synthetic Opioids Product Portfolio Table 70. Endo International Recent Development Table 71. Impax Laboratories Company Information Table 72. Impax Laboratories Business Overview Table 73. Impax Laboratories Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Impax Laboratories Synthetic Opioids Product Portfolio Table 75. Impax Laboratories Recent Development Table 76. Indivior Company Information Table 77. Indivior Business Overview Table 78. Indivior Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Indivior Synthetic Opioids Product Portfolio Table 80. Indivior Recent Development Table 81. Janssen Pharmaceuticals Company Information Table 82. Janssen Pharmaceuticals Business Overview Table 83. Janssen Pharmaceuticals Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Janssen Pharmaceuticals Synthetic Opioids Product Portfolio Table 85. Janssen Pharmaceuticals Recent Development Table 86. Mallinckrodt Pharmaceuticals Company Information Table 87. Mallinckrodt Pharmaceuticals Business Overview Table 88. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio Table 90. Mallinckrodt Pharmaceuticals Recent Development Table 91. Purdue Pharma Company Information Table 92. Purdue Pharma Business Overview Table 93. Purdue Pharma Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Purdue Pharma Synthetic Opioids Product Portfolio Table 95. Purdue Pharma Recent Development Table 96. West-Ward Pharmaceuticals Company Information Table 97. West-Ward Pharmaceuticals Business Overview Table 98. West-Ward Pharmaceuticals Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio Table 100. West-Ward Pharmaceuticals Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Pfizer Synthetic Opioids Product Portfolio Table 105. Pfizer Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Mylan Synthetic Opioids Product Portfolio Table 110. Mylan Recent Development Table 111. Teva Pharmaceuticals Company Information Table 112. Teva Pharmaceuticals Business Overview Table 113. Teva Pharmaceuticals Synthetic Opioids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Teva Pharmaceuticals Synthetic Opioids Product Portfolio Table 115. Teva Pharmaceuticals Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Synthetic Opioids Distributors List Table 119. Synthetic Opioids Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Synthetic Opioids Product Image Figure 2. Global Synthetic Opioids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Opioids Market Size (2021-2032) & (US$ Million) Figure 4. Global Synthetic Opioids Sales (2021-2032) & (K Units) Figure 5. Global Synthetic Opioids Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Synthetic Opioids Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hydrocodone Image Figure 9. Oxymorphone Image Figure 10. Oxycodone Image Figure 11. Meperidine Image Figure 12. Methadone Image Figure 13. Fentanyl Image Figure 14. Global Synthetic Opioids Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Synthetic Opioids Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Synthetic Opioids Sales Market Share by Type (2021-2032) Figure 17. Global Synthetic Opioids Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Synthetic Opioids Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Synthetic Opioids Revenue Market Share by Type (2021-2032) Figure 20. Pain Management Image Figure 21. De-addiction Image Figure 22. Global Synthetic Opioids Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Synthetic Opioids Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Synthetic Opioids Sales Market Share by Application (2021-2032) Figure 25. Global Synthetic Opioids Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Synthetic Opioids Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Synthetic Opioids Revenue Market Share by Application (2021-2032) Figure 28. North America Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 30. U.S. Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 35. Germany Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 42. China Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 50. Brazil Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Synthetic Opioids Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Synthetic Opioids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Synthetic Opioids Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Synthetic Opioids Revenue (2021-2032) & (US$ Million) Figure 61. North America Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Synthetic Opioids Revenue (2021-2032) & (US$ Million) Figure 63. Europe Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Synthetic Opioids Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Synthetic Opioids Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Synthetic Opioids Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Synthetic Opioids Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hydrocodone
  • Oxymorphone
  • Oxycodone
  • Meperidine
  • Methadone
  • Fentanyl
Applications
  • Pain Management
  • De-addiction
Companies covered
  • Endo International
  • Impax Laboratories
  • Indivior
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • West-Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Synthetic Opioids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Synthetic Opioids Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Synthetic Opioids Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Synthetic Opioids Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Synthetic Opioids Market Dynamics
  1. 2.1 Synthetic Opioids Industry Trends
  2. 2.2 Synthetic Opioids Industry Drivers
  3. 2.3 Synthetic Opioids Industry Opportunities and Challenges
  4. 2.4 Synthetic Opioids Industry Restraints
3 Synthetic Opioids Market by Manufacturers
  1. 3.1 Global Synthetic Opioids Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Synthetic Opioids Sales by Manufacturers (2021-2026)
  3. 3.3 Global Synthetic Opioids Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Synthetic Opioids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Synthetic Opioids Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Synthetic Opioids Manufacturers, Product Type & Application
  7. 3.7 Global Synthetic Opioids Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Synthetic Opioids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Synthetic Opioids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Synthetic Opioids Tier 1, Tier 2, and Tier 3
4 Synthetic Opioids Market by Type
  1. 4.1 Synthetic Opioids Type Introduction
  2. 4.1.1 Hydrocodone
  3. 4.1.2 Oxymorphone
  4. 4.1.3 Oxycodone
  5. 4.1.4 Meperidine
  6. 4.1.5 Methadone
  7. 4.1.6 Fentanyl
  8. 4.2 Global Synthetic Opioids Sales by Type
  9. 4.2.1 Global Synthetic Opioids Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Synthetic Opioids Sales by Type (2021-2032)
  11. 4.2.3 Global Synthetic Opioids Sales Market Share by Type (2021-2032)
  12. 4.3 Global Synthetic Opioids Revenue by Type
  13. 4.3.1 Global Synthetic Opioids Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Synthetic Opioids Revenue by Type (2021-2032)
  15. 4.3.3 Global Synthetic Opioids Revenue Market Share by Type (2021-2032)
5 Synthetic Opioids Market by Application
  1. 5.1 Synthetic Opioids Application Introduction
  2. 5.1.1 Pain Management
  3. 5.1.2 De-addiction
  4. 5.2 Global Synthetic Opioids Sales by Application
  5. 5.2.1 Global Synthetic Opioids Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Synthetic Opioids Sales by Application (2021-2032)
  7. 5.2.3 Global Synthetic Opioids Sales Market Share by Application (2021-2032)
  8. 5.3 Global Synthetic Opioids Revenue by Application
  9. 5.3.1 Global Synthetic Opioids Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Synthetic Opioids Revenue by Application (2021-2032)
  11. 5.3.3 Global Synthetic Opioids Revenue Market Share by Application (2021-2032)
6 Global Synthetic Opioids Sales by Region
  1. 6.1 Global Synthetic Opioids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Synthetic Opioids Sales by Region (2021-2032)
  3. 6.2.1 Global Synthetic Opioids Sales by Region (2021-2026)
  4. 6.2.2 Global Synthetic Opioids Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Synthetic Opioids Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Synthetic Opioids Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Synthetic Opioids Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Synthetic Opioids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Synthetic Opioids Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Synthetic Opioids Revenue by Region
  1. 7.1 Global Synthetic Opioids Revenue by Region
  2. 7.1.1 Global Synthetic Opioids Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Synthetic Opioids Revenue by Region (2021-2026)
  4. 7.1.3 Global Synthetic Opioids Revenue by Region (2027-2032)
  5. 7.1.4 Global Synthetic Opioids Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Synthetic Opioids Revenue (2021-2032)
  8. 7.2.2 North America Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Synthetic Opioids Revenue (2021-2032)
  11. 7.3.2 Europe Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Synthetic Opioids Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Synthetic Opioids Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Synthetic Opioids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Endo International
  2. 8.1.1 Endo International Company Information
  3. 8.1.2 Endo International Business Overview
  4. 8.1.3 Endo International Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Endo International Synthetic Opioids Product Portfolio
  6. 8.1.5 Endo International Recent Developments
  7. 8.2 Impax Laboratories
  8. 8.2.1 Impax Laboratories Company Information
  9. 8.2.2 Impax Laboratories Business Overview
  10. 8.2.3 Impax Laboratories Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Impax Laboratories Synthetic Opioids Product Portfolio
  12. 8.2.5 Impax Laboratories Recent Developments
  13. 8.3 Indivior
  14. 8.3.1 Indivior Company Information
  15. 8.3.2 Indivior Business Overview
  16. 8.3.3 Indivior Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Indivior Synthetic Opioids Product Portfolio
  18. 8.3.5 Indivior Recent Developments
  19. 8.4 Janssen Pharmaceuticals
  20. 8.4.1 Janssen Pharmaceuticals Company Information
  21. 8.4.2 Janssen Pharmaceuticals Business Overview
  22. 8.4.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Janssen Pharmaceuticals Synthetic Opioids Product Portfolio
  24. 8.4.5 Janssen Pharmaceuticals Recent Developments
  25. 8.5 Mallinckrodt Pharmaceuticals
  26. 8.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 8.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 8.5.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio
  30. 8.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 8.6 Purdue Pharma
  32. 8.6.1 Purdue Pharma Company Information
  33. 8.6.2 Purdue Pharma Business Overview
  34. 8.6.3 Purdue Pharma Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Purdue Pharma Synthetic Opioids Product Portfolio
  36. 8.6.5 Purdue Pharma Recent Developments
  37. 8.7 West-Ward Pharmaceuticals
  38. 8.7.1 West-Ward Pharmaceuticals Company Information
  39. 8.7.2 West-Ward Pharmaceuticals Business Overview
  40. 8.7.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio
  42. 8.7.5 West-Ward Pharmaceuticals Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Synthetic Opioids Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Synthetic Opioids Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Teva Pharmaceuticals
  56. 8.10.1 Teva Pharmaceuticals Company Information
  57. 8.10.2 Teva Pharmaceuticals Business Overview
  58. 8.10.3 Teva Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Pharmaceuticals Synthetic Opioids Product Portfolio
  60. 8.10.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Synthetic Opioids Value Chain Analysis
  2. 9.1.1 Synthetic Opioids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Synthetic Opioids Production Mode & Process
  6. 9.2 Synthetic Opioids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Synthetic Opioids Distributors
  9. 9.2.3 Synthetic Opioids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst